In vitro and in vivo studies will be crucial next steps – for example, overexpressing or knocking down MEIS3 in cardiac fibroblasts to observe effects on cytokine production, or using a mouse model of cardiac hypertrophy to test if MEIS3 loss-of-function alters inflammatory cell infiltration and fibrosis. The gene discussed is MEIS3; the disease is cardiac hypertrophy.